|Established||October 13, 2010|
|Capital||10 million yen|
|Board of Directors||
1. Providing innovative research products, services and technologies in protein engineering and drug discovery.
2. Development of Novel Biologics including Therapeutic Monoclonal Antibody.
|Contact||SHARP Kashiwa Building, 4F
273-1 Kashiwa, Kashiwa-shi, Chiba 277-0005, Japan
|Please contact here|